These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25321172)

  • 21. Time-resolved fluorescence microscopy (FLIM) as an analytical tool in skin nanomedicine.
    Alexiev U; Volz P; Boreham A; Brodwolf R
    Eur J Pharm Biopharm; 2017 Jul; 116():111-124. PubMed ID: 28115230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
    Puglia C; Blasi P; Rizza L; Schoubben A; Bonina F; Rossi C; Ricci M
    Int J Pharm; 2008 Jun; 357(1-2):295-304. PubMed ID: 18343059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (Phospho)lipid-based Nanosystems for Skin Administration.
    Vanić Z; Holæter AM; Skalko-Basnet N
    Curr Pharm Des; 2015; 21(29):4174-92. PubMed ID: 26323431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications.
    Greenhalgh K; Turos E
    Nanomedicine; 2009 Mar; 5(1):46-54. PubMed ID: 18824416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
    Shokeen M; Fettig NM; Rossin R
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
    Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
    Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
    Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
    Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy.
    Jung SH; Cho YS; Jun SS; Koo JS; Cheon HG; Shin BC
    Pharmazie; 2011 Jun; 66(6):430-5. PubMed ID: 21699082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy.
    Pople PV; Singh KK
    Int J Pharm; 2012 Sep; 434(1-2):70-9. PubMed ID: 22609427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new concept for the treatment of atopic dermatitis: silver-nanolipid complex (sNLC).
    Keck CM; Anantaworasakul P; Patel M; Okonogi S; Singh KK; Roessner D; Scherrers R; Schwabe K; Rimpler C; Müller RH
    Int J Pharm; 2014 Feb; 462(1-2):44-51. PubMed ID: 24378329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of drug delivery systems for the dermal application of therapeutic DNAzymes.
    Schmidts T; Marquardt K; Schlupp P; Dobler D; Heinz F; Mäder U; Garn H; Renz H; Zeitvogel J; Werfel T; Runkel F
    Int J Pharm; 2012 Jul; 431(1-2):61-9. PubMed ID: 22531847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin penetration and distribution of polymeric nanoparticles.
    Alvarez-Román R; Naik A; Kalia YN; Guy RH; Fessi H
    J Control Release; 2004 Sep; 99(1):53-62. PubMed ID: 15342180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanocarrier-based topical drug delivery for the treatment of skin diseases.
    Gupta M; Agrawal U; Vyas SP
    Expert Opin Drug Deliv; 2012 Jul; 9(7):783-804. PubMed ID: 22559240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
    Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
    Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carriers in the topical treatment of skin disease.
    Korting HC; Schäfer-Korting M
    Handb Exp Pharmacol; 2010; (197):435-68. PubMed ID: 20217539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced delivery of nano- and submicron particles using elongated microparticles.
    Raphael AP; Sisney JP; Liu DC; Prow TW
    Curr Drug Deliv; 2015; 12(1):78-85. PubMed ID: 25176162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.